Table 3.
Association Between AD-GRS and Body Mass Index Stratified by Agea, UK Biobank, United Kingdom, 2006–2010
| Primary AD-GRS 2013 Score b | 2019 Score c | ||||
|---|---|---|---|---|---|
| Age Group, years | No. |
|
95% CI |
|
95% CI |
| 39–49 | 88,758 | 0.00 | −0.03, 0.03 | 0.00 | −0.04, 0.02 |
| 50–59 | 134,163 | −0.03 | −0.06, −0.01 | −0.04 | −0.07, −0.01 |
| 60–73 | 184,465 | −0.09 | −0.12, −0.07 | −0.09 | −0.11, −0.07 |
Abbreviations: AD-GRS, Alzheimer’s disease genetic risk score; CI, confidence interval; GWAS, genome-wide association study; SNP, single nucleotide polymorphism.
a Reaction time was measured in milliseconds. Models adjusted for age, age2, sex, and principle components to account for confounding by population stratification.
b AD-GRS of 23 SNPs using estimates from 2013 GWAS meta-analysis.
c AD-GRS of 27 SNPs using estimates from 2019 GWAS meta-analysis.